1. Home
  2. HRMY vs SIMO Comparison

HRMY vs SIMO Comparison

Compare HRMY & SIMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$38.13

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Logo Silicon Motion Technology Corporation

SIMO

Silicon Motion Technology Corporation

HOLD

Current Price

$90.33

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
SIMO
Founded
2017
1995
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
3.2B
IPO Year
2020
2005

Fundamental Metrics

Financial Performance
Metric
HRMY
SIMO
Price
$38.13
$90.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
8
Target Price
$51.33
$103.13
AVG Volume (30 Days)
695.1K
266.7K
Earning Date
11-04-2025
02-04-2026
Dividend Yield
N/A
2.22%
EPS Growth
50.44
8.75
EPS
3.17
2.87
Revenue
$825,944,000.00
$798,326,000.00
Revenue This Year
$23.11
$10.15
Revenue Next Year
$16.15
$17.72
P/E Ratio
$12.04
$31.44
Revenue Growth
21.13
N/A
52 Week Low
$25.52
$37.21
52 Week High
$40.93
$106.60

Technical Indicators

Market Signals
Indicator
HRMY
SIMO
Relative Strength Index (RSI) 57.61 53.00
Support Level $37.12 $87.98
Resistance Level $39.60 $91.19
Average True Range (ATR) 1.21 3.03
MACD -0.34 0.19
Stochastic Oscillator 28.27 54.21

Price Performance

Historical Comparison
HRMY
SIMO

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

Share on Social Networks: